Cardinal Health (CAH) Financials

$153.93 +0.80 (+0.53%)

Closing price 03:59 PM Eastern

Extended Trading

$155.00 +1.07 (+0.69%)

As of 07:38 PM Eastern

Annual Income Statements for Cardinal Health

This table shows Cardinal Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Income / (Loss) Attributable to Common Shareholders	852	330	-938	611	-3,696	1,363	256	1,288	1,427	1,215
Consolidated Net Income / (Loss)	853	331	-937	612	-3,693	1,365	259	1,294	1,431	1,215
Net Income / (Loss) Continuing Operations	853	331	-937	612	-3,693	1,365	259	1,294	1,431	1,212
Total Pre-Tax Income	1,201	663	-784	323	-3,772	1,751	-228	1,924	2,276	1,967
Total Operating Income	1,243	752	-607	472	-4,098	2,060	126	2,120	2,459	2,161
Total Gross Profit	7,414	6,874	6,484	6,778	6,868	6,834	7,181	6,544	6,543	5,712
Total Revenue	226,827	204,979	181,326	162,467	152,922	145,534	136,809	129,976	121,546	102,531
Operating Revenue	226,827	204,979	181,326	162,467	152,922	145,534	136,809	129,976	121,546	102,531
Total Cost of Revenue	219,413	198,105	174,842	155,689	146,054	138,700	129,628	123,432	115,003	96,819
Operating Cost of Revenue	219,413	198,105	174,842	155,689	146,054	138,700	129,628	123,432	115,003	96,819
Total Operating Expenses	6,171	6,122	7,091	6,306	10,966	4,774	7,055	4,424	4,084	3,551
Selling, General & Admin Expense	5,000	4,800	4,512	4,533	4,572	4,480	4,596	3,775	3,648	3,240
Amortization Expense	284	285	324	451	524	621	707	527	459	281
Impairment Charge	634	1,246	2,060	79	7.00	-488	1,417	18	21	-19
Restructuring Charge	175	95	101	114	122	125	176	56	25	44
Other Special Charges / (Income)	78	-304	94	1,129	5,741	36	159	48	-69	5.00
Total Other Income / (Expense), net	-42	-89	-177	-149	326	-309	-354	-196	-183	-194
Interest Expense	51	84	157	194	254	294	331	201	178	201
Interest & Investment Income	0.00	0.00	2.00	-2.00	579	0.00	0.00	-	-	-
Other Income / (Expense), net	9.00	-5.00	-22	47	1.00	-15	-23	5.00	-5.00	7.00
Income Tax Expense	348	332	153	-289	-79	386	-487	630	845	755
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	1.00	1.00	1.00	3.00	2.00	3.00	6.00	4.00	0.00
Basic Earnings per Share	$3.48	$1.27	($3.37)	$2.09	($12.61)	$4.55	$0.82	$4.06	$4.36	$3.66
Weighted Average Basic Shares Outstanding	245M	261M	279M	292M	293M	300M	313M	317M	327M	332M
Diluted Earnings per Share	$3.45	$1.26	($3.37)	$2.08	($12.61)	$4.53	$0.81	$4.03	$4.32	$3.62
Weighted Average Diluted Shares Outstanding	247M	262M	279M	294M	293M	301M	315M	320M	330M	335M
Weighted Average Basic & Diluted Shares Outstanding	243.85M	250.68M	272.51M	290.44M	292.44M	299.60M	312.20M	317.20M	327.30M	332M
Cash Dividends to Common per Share	$2.00	$1.98	$1.96	$1.94	$1.92	$1.91	$1.85	$1.80	$1.55	$1.37

This table shows Cardinal Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	506	400	416	236	258	368	-12	5.00	345	-130	110
Consolidated Net Income / (Loss)	508	401	417	234	259	369	-11	3.00	347	-130	111
Net Income / (Loss) Continuing Operations	508	401	417	234	259	369	-11	3.00	347	-130	111
Total Pre-Tax Income	665	511	541	396	341	512	-44	146	544	-137	110
Total Operating Income	730	549	568	408	367	505	-32	162	572	-119	137
Total Gross Profit	2,123	1,941	1,902	1,853	1,947	1,854	1,743	1,812	1,785	1,663	1,614
Total Revenue	54,878	55,264	52,277	59,708	54,911	57,442	54,650	53,420	50,487	51,469	49,603
Operating Revenue	54,878	55,264	52,277	59,708	54,911	57,442	54,650	53,420	50,487	51,469	49,603
Total Cost of Revenue	52,755	53,323	50,375	57,855	52,964	55,588	52,907	51,608	48,702	49,806	47,989
Operating Cost of Revenue	52,755	53,323	50,375	57,855	52,964	55,588	52,907	51,608	48,702	49,806	47,989
Total Operating Expenses	1,393	1,392	1,334	1,445	1,580	1,349	1,775	1,650	1,213	1,782	1,477
Selling, General & Admin Expense	1,315	1,306	1,277	1,238	1,282	1,268	1,186	1,233	1,179	1,191	1,197
Amortization Expense	152	105	74	77	80	63	64	69	74	71	71
Other Operating Expenses / (Income)	20	-	-	-	-	-	-	-	-	-	-
Impairment Charge	-17	3.00	-1.00	12	84	1.00	541	363	20	710	153
Restructuring Charge	28	9.00	24	69	53	28	25	33	16	17	29
Other Special Charges / (Income)	-105	-31	-40	49	81	-11	-41	-48	-76	-207	27
Total Other Income / (Expense), net	-65	-38	-27	-12	-26	7.00	-12	-16	-28	-18	-27
Interest Expense	74	35	32	-4.00	33	3.00	11	6.00	28	25	25
Other Income / (Expense), net	9.00	-3.00	5.00	-16	7.00	10	-1.00	-10	0.00	7.00	-2.00
Income Tax Expense	157	110	124	162	82	143	-33	143	197	-7.00	-1.00
Net Income / (Loss) Attributable to Noncontrolling Interest	2.00	1.00	1.00	-2.00	1.00	1.00	1.00	-2.00	2.00	0.00	1.00
Weighted Average Basic Shares Outstanding	240M	242M	243M	245M	243M	245M	249M	261M	256M	261M	271M
Weighted Average Diluted Shares Outstanding	241M	243M	245M	247M	245M	246M	249M	262M	258M	261M	273M
Weighted Average Basic & Diluted Shares Outstanding	238.68M	241.57M	242.01M	243.85M	243.57M	243.23M	246.47M	250.68M	254.60M	257.64M	262.13M
Cash Dividends to Common per Share	$0.51	$0.51	$0.51	$0.50	$0.50	$0.50	$0.50	$0.49	$0.50	$0.50	$0.50

This table details how cash moves in and out of Cardinal Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Change in Cash & Equivalents	1,057	-669	1,363	636	240	768	-5,116	4,523	-2,260	1,751
Net Cash From Operating Activities	3,762	2,844	3,175	2,429	1,960	2,722	2,768	1,184	2,971	2,540
Net Cash From Continuing Operating Activities	3,762	2,844	3,175	2,429	1,960	2,719	2,768	1,184	2,971	2,543
Net Income / (Loss) Continuing Operations	853	331	-937	612	-3,693	1,365	259	1,294	1,431	1,215
Consolidated Net Income / (Loss)	853	331	-937	612	-3,693	1,365	259	1,294	1,431	1,215
Depreciation Expense	710	692	692	783	913	1,000	1,032	717	641	451
Non-Cash Adjustments To Reconcile Net Income	793	1,364	2,210	249	-360	-318	1,584	154	205	198
Changes in Operating Assets and Liabilities, net	1,406	457	1,210	785	5,100	672	-107	-981	694	679
Net Cash From Investing Activities	-1,849	-454	567	-378	493	338	-5,608	-405	-4,080	-849
Net Cash From Continuing Investing Activities	-1,849	-454	567	-378	493	338	-5,608	-405	-4,080	-849
Purchase of Property, Plant & Equipment	-511	-481	-387	-400	-375	-328	-384	-387	-465	-300
Acquisitions	-1,190	-10	-22	-3.00	0.00	-82	-6,142	-132	-3,614	-503
Purchase of Investments	-4.00	-7.00	-78	-22	-20	-18	-9.00	-194	-200	-342
Sale of Property, Plant & Equipment	12	12	31	0.00	2.00	-	-	-	-	-
Divestitures	9.00	0.00	923	0.00	0.00	763	862	3.00	13	53
Sale and/or Maturity of Investments	35	32	100	47	886	3.00	65	305	186	243
Other Investing Activities, net	-200	0.00	0.00	-	-	-	-	-	-	-
Net Cash From Financing Activities	-847	-3,051	-2,463	-1,317	-2,200	-2,293	-2,276	3,746	-1,139	60
Net Cash From Continuing Financing Activities	-847	-3,051	-2,463	-1,317	-2,200	-2,293	-2,276	3,746	-1,139	60
Repayment of Debt	-783	-579	-885	-570	-1,401	-1,102	-1,004	-310	-6.00	-1,233
Repurchase of Common Equity	-750	-2,000	-1,000	-200	-350	-600	-550	-600	-651	-1,036
Payment of Dividends	-499	-528	-559	-573	-569	-577	-581	-577	-512	-460
Issuance of Debt	1,139	0.00	0.00	-	-	0.00	3.00	5,174	26	2,672
Other Financing Activities, net	46	56	-19	26	120	-14	-144	59	4.00	117
Effect of Exchange Rate Changes	-9.00	-8.00	-25	11	-13	1.00	4.00	-2.00	-12	0.00
Cash Interest Paid	214	203	153	182	226	285	320	200	174	150
Cash Income Taxes Paid	191	156	-766	273	368	311	425	686	635	529

This table details how cash moves in and out of Cardinal Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-484	943	-2,266	1,382	-873	727	-206	58	336	162	-1,225
Net Cash From Operating Activities	2,917	-400	-1,647	2,077	-49	1,179	528	863	1,361	597	23
Net Cash From Continuing Operating Activities	2,917	-398	-1,649	2,077	-49	1,179	528	863	1,361	597	23
Net Income / (Loss) Continuing Operations	508	401	417	234	259	369	-11	3.00	347	-130	111
Consolidated Net Income / (Loss)	508	401	417	234	259	369	-11	3.00	347	-130	111
Depreciation Expense	207	192	182	186	177	175	172	176	175	170	171
Non-Cash Adjustments To Reconcile Net Income	27	48	44	24	131	41	579	333	61	765	205
Changes in Operating Assets and Liabilities, net	2,175	-1,039	-2,292	1,633	-616	594	-212	351	778	-208	-464
Net Cash From Investing Activities	-2,898	-976	-88	166	-1,847	-105	-63	-206	-91	-87	-70
Net Cash From Continuing Investing Activities	-2,898	-976	-88	166	-1,847	-105	-63	-206	-91	-87	-70
Purchase of Property, Plant & Equipment	-126	-99	-90	-193	-112	-114	-92	-217	-109	-85	-70
Acquisitions	-2,779	-	-	2.00	-	-	-	-	-	-	-
Purchase of Investments	-3.00	-	-	-1.00	-1.00	-	-	-1.00	-1.00	-2.00	-3.00
Sale of Property, Plant & Equipment	3.00	-	0.00	2.00	8.00	1.00	1.00	10	-	-	2.00
Sale and/or Maturity of Investments	7.00	2.00	0.00	6.00	-	1.00	28	2.00	29	-	1.00
Net Cash From Financing Activities	-507	2,331	-540	-859	1,031	-353	-666	-592	-934	-362	-1,163
Net Cash From Continuing Financing Activities	-507	2,331	-540	-859	1,031	-353	-666	-592	-934	-362	-1,163
Repayment of Debt	-11	-414	-9.00	-760	-8.00	-8.00	-7.00	-8.00	-558	-6.00	-7.00
Repurchase of Common Equity	-375	-15	-375	-	-	-250	-500	-500	-250	-250	-1,000
Payment of Dividends	-124	-122	-128	-122	-122	-124	-131	-129	-128	-129	-142
Other Financing Activities, net	3.00	13	-28	23	22	29	-28	45	2.00	23	-14

This table presents Cardinal Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Total Assets	45,121	43,349	43,878	44,453	40,766	40,963	39,951	40,112	34,122	30,142
Total Current Assets	34,884	33,737	32,935	31,048	25,940	25,747	24,553	28,345	21,956	21,752
Cash & Equivalents	5,133	4,076	4,717	3,407	2,771	2,531	1,763	6,879	2,356	4,616
Accounts Receivable	12,084	11,108	10,561	9,103	8,264	8,448	7,800	8,048	7,405	6,523
Inventories, net	14,957	16,119	15,636	14,594	13,198	12,822	12,308	11,301	10,615	9,211
Other Current Assets	2,663	2,294	2,021	2,843	1,707	1,946	1,926	2,117	1,580	1,402
Other Current Nonoperating Assets	47	140	0.00	1,101	0.00	-	756	0.00	-	-
Plant, Property, & Equipment, net	2,529	2,461	2,361	2,360	2,366	2,356	2,487	1,879	1,796	1,506
Total Noncurrent Assets	7,708	7,151	8,582	11,045	12,460	12,860	12,911	9,888	10,370	6,884
Goodwill	6,450	6,085	7,629	10,094	11,275	11,808	12,229	9,207	9,426	6,018
Other Noncurrent Operating Assets	1,258	1,066	953	951	1,185	1,052	682	681	944	866
Total Liabilities & Shareholders' Equity	45,121	43,349	43,878	44,453	40,766	40,963	39,951	40,112	34,122	30,142
Total Liabilities	48,333	46,306	44,584	42,659	38,974	34,633	33,880	33,166	27,434	23,605
Total Current Liabilities	35,640	33,740	30,550	27,624	23,615	24,109	22,893	21,221	19,701	17,243
Short-Term Debt	434	792	580	871	10	452	1,001	1,327	587	-
Accounts Payable	31,759	29,934	27,128	23,700	21,374	21,535	19,677	17,906	17,306	14,368
Accrued Expenses	3,447	2,972	2,842	2,957	2,231	2,122	2,002	1,988	1,808	2,594
Total Noncurrent Liabilities	12,693	12,566	14,034	15,035	15,359	10,524	10,987	11,945	7,733	6,643
Long-Term Debt	4,658	3,909	4,735	5,365	6,765	7,579	8,012	9,068	4,952	5,211
Noncurrent Deferred & Payable Income Tax Liabilities	8,035	8,657	9,299	9,670	8,594	2,945	2,975	2,877	2,781	1,432
Total Equity & Noncontrolling Interests	-3,212	-2,957	-706	1,794	1,792	6,330	6,059	6,828	6,571	6,256
Total Preferred & Common Equity	-3,213	-2,958	-709	1,791	1,789	6,328	6,059	6,808	6,554	6,256
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Total Common Equity	-3,213	-2,958	-709	1,791	1,789	6,328	6,059	6,808	6,554	6,256
Common Stock	2,917	2,746	2,813	2,806	2,789	2,763	2,730	2,697	3,010	3,003
Retained Earnings	-286	-642	-280	1,205	1,170	5,434	4,645	4,967	6,419	5,521
Treasury Stock	-5,677	-4,911	-3,128	-2,186	-2,066	-1,790	-1,224	-731	-2,759	-2,245
Accumulated Other Comprehensive Income / (Loss)	-167	-151	-114	-34	-104	-79	-92	-125	-116	-23
Noncontrolling Interest	1.00	1.00	3.00	3.00	3.00	2.00	0.00	20	17	0.00

This table presents Cardinal Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	49,871	47,002	43,059	45,121	45,880	46,573	43,710	43,349	43,377	44,482	43,387
Total Current Assets	34,595	35,756	32,905	34,884	35,734	37,658	34,688	33,737	33,497	34,596	32,696
Cash & Equivalents	3,326	3,810	2,867	5,133	3,718	4,591	3,854	4,076	3,990	3,654	3,492
Accounts Receivable	12,666	12,369	11,781	12,084	11,566	11,788	11,265	11,108	10,992	11,421	11,039
Inventories, net	16,158	16,904	15,619	14,957	17,277	18,451	16,987	16,119	16,620	17,263	15,891
Other Current Assets	2,398	2,623	2,591	2,663	3,161	2,816	2,582	2,294	1,895	2,258	2,274
Other Current Nonoperating Assets	47	50	47	47	12	12	0.00	140	-	-	-
Plant, Property, & Equipment, net	2,664	2,558	2,535	2,529	2,470	2,446	2,441	2,461	2,362	2,341	2,339
Total Noncurrent Assets	12,612	8,688	7,619	7,708	7,676	6,469	6,581	7,151	7,518	7,545	8,352
Goodwill	11,014	7,436	6,388	6,450	6,507	5,371	5,432	6,085	6,567	6,618	7,367
Other Noncurrent Operating Assets	1,598	1,252	1,231	1,258	1,169	1,098	1,149	1,066	951	927	985
Total Liabilities & Shareholders' Equity	49,871	47,002	43,059	45,121	45,880	46,573	43,710	43,349	43,377	44,482	43,387
Total Liabilities	51,769	49,923	46,335	48,333	49,142	50,020	47,200	46,306	45,595	46,694	45,167
Total Current Liabilities	36,662	35,223	34,678	35,640	36,306	38,286	35,065	33,740	32,503	33,212	31,559
Short-Term Debt	543	544	940	434	1,187	1,188	788	792	-	577	578
Accounts Payable	32,812	31,298	30,365	31,759	32,089	34,259	31,540	29,934	29,601	30,083	28,362
Accrued Expenses	3,307	3,381	3,373	3,447	3,030	2,839	2,737	2,972	2,876	2,552	2,619
Total Noncurrent Liabilities	15,107	14,700	11,657	12,693	12,836	11,734	12,135	12,566	13,092	13,482	13,608
Long-Term Debt	7,136	7,062	4,224	4,658	4,667	3,535	3,890	3,909	4,708	4,685	4,689
Noncurrent Deferred & Payable Income Tax Liabilities	7,971	7,638	7,433	8,035	8,169	8,199	8,245	8,657	8,384	8,797	8,919
Total Equity & Noncontrolling Interests	-1,898	-2,921	-3,276	-3,212	-3,262	-3,447	-3,490	-2,957	-2,218	-2,212	-1,780
Total Preferred & Common Equity	-2,948	-2,991	-3,277	-3,213	-3,265	-3,449	-3,491	-2,958	-2,220	-2,213	-1,781
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	-2,948	-2,991	-3,277	-3,213	-3,265	-3,449	-3,491	-2,958	-2,220	-2,213	-1,781
Common Stock	2,946	2,932	2,827	2,917	2,887	2,855	2,728	2,746	2,818	2,747	2,576
Retained Earnings	664	283	14	-286	-289	-425	-654	-642	-342	-560	-301
Treasury Stock	-6,382	-6,026	-5,963	-5,677	-5,703	-5,724	-5,400	-4,911	-4,554	-4,254	-3,880
Accumulated Other Comprehensive Income / (Loss)	-176	-180	-155	-167	-160	-155	-165	-151	-142	-146	-176
Noncontrolling Interest	1,050	70	1.00	1.00	3.00	2.00	1.00	1.00	2.00	1.00	1.00

This table displays calculated financial ratios and metrics derived from Cardinal Health's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.66%	13.04%	11.61%	6.24%	5.08%	6.38%	5.26%	6.94%	18.55%	12.57%
EBITDA Growth	36.34%	2,184.13%	-95.16%	140.89%	-204.56%	168.28%	-60.06%	-8.17%	18.17%	9.58%
EBIT Growth	67.60%	218.76%	-221.19%	112.67%	-300.34%	1,885.44%	-95.15%	-13.41%	13.19%	12.27%
NOPAT Growth	135.15%	188.36%	-147.51%	131.18%	-278.63%	1,720.73%	-93.81%	-7.78%	16.11%	9.21%
Net Income Growth	157.70%	135.33%	-253.10%	116.57%	-370.55%	427.03%	-79.98%	-9.57%	17.78%	4.20%
EPS Growth	173.81%	137.39%	-262.02%	116.49%	-378.37%	459.26%	-79.90%	-6.71%	19.34%	7.10%
Operating Cash Flow Growth	32.28%	-10.43%	30.71%	23.93%	-27.99%	-1.66%	133.78%	-60.15%	16.97%	0.63%
Free Cash Flow Firm Growth	-35.02%	-18.29%	7.45%	-2.94%	23.94%	214.64%	-366.86%	169.98%	-169.86%	4.16%
Invested Capital Growth	-35.80%	-2,150.00%	-102.99%	-37.58%	-51.01%	-7.42%	22.14%	5.99%	38.40%	-5.01%
Revenue Q/Q Growth	2.85%	3.20%	2.53%	3.77%	-0.43%	1.40%	1.77%	1.23%	3.26%	4.76%
EBITDA Q/Q Growth	14.60%	12.51%	-75.10%	-10.88%	-0.89%	85.22%	-56.76%	-5.42%	4.14%	6.90%
EBIT Q/Q Growth	23.72%	27.91%	-42.95%	-18.01%	-0.29%	223.58%	-93.77%	-7.77%	2.59%	8.45%
NOPAT Q/Q Growth	35.39%	-37.10%	-29.15%	36.15%	-0.94%	15,504.10%	-95.80%	-2.58%	3.30%	4.52%
Net Income Q/Q Growth	37.14%	-28.04%	1.78%	-46.97%	11.14%	27,200.00%	-84.79%	-4.22%	2.88%	5.29%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.16%
Operating Cash Flow Q/Q Growth	47.65%	-43.41%	299.37%	21.21%	-11.95%	-1.73%	-5.79%	7.54%	-7.10%	6.37%
Free Cash Flow Firm Q/Q Growth	454.54%	-41.79%	190.85%	10.96%	9.42%	-17.33%	-12.63%	117.67%	-7.53%	14.14%
Invested Capital Q/Q Growth	-189.98%	-64.86%	-104.21%	-10.16%	-5.59%	-0.37%	-14.55%	-3.80%	0.78%	-0.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	3.27%	3.35%	3.58%	4.17%	4.49%	4.70%	5.25%	5.03%	5.38%	5.57%
EBITDA Margin	0.87%	0.70%	0.03%	0.80%	-2.08%	2.09%	0.83%	2.19%	2.55%	2.55%
Operating Margin	0.55%	0.37%	-0.33%	0.29%	-2.68%	1.42%	0.09%	1.63%	2.02%	2.11%
EBIT Margin	0.55%	0.36%	-0.35%	0.32%	-2.68%	1.41%	0.08%	1.63%	2.02%	2.11%
Profit (Net Income) Margin	0.38%	0.16%	-0.52%	0.38%	-2.42%	0.94%	0.19%	1.00%	1.18%	1.19%
Tax Burden Percent	71.02%	49.92%	119.52%	189.47%	97.91%	77.96%	-113.60%	67.26%	62.87%	61.77%
Interest Burden Percent	95.93%	88.76%	124.64%	62.24%	92.07%	85.62%	-221.36%	90.54%	92.75%	90.73%
Effective Tax Rate	28.98%	50.08%	0.00%	-89.47%	0.00%	22.04%	0.00%	32.74%	37.13%	38.38%
Return on Invested Capital (ROIC)	0.00%	0.00%	-24.21%	19.00%	-32.55%	13.05%	0.76%	14.02%	18.19%	18.19%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-66.50%	9.31%	-49.90%	9.11%	4.10%	10.09%	12.52%	6.44%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-148.03%	15.13%	-58.39%	8.96%	3.22%	4.96%	3.92%	1.01%
Return on Equity (ROE)	-27.65%	-18.07%	-172.24%	34.13%	-90.94%	22.01%	3.98%	18.98%	22.11%	19.20%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	65.27%	35.92%	20.76%	-19.17%	8.21%	-14.03%	23.33%
Operating Return on Assets (OROA)	2.83%	1.71%	-1.42%	1.22%	-10.03%	5.05%	0.26%	5.73%	7.64%	7.72%
Return on Assets (ROA)	1.93%	0.76%	-2.12%	1.44%	-9.04%	3.37%	0.65%	3.49%	4.45%	4.33%
Return on Common Equity (ROCE)	-27.66%	-18.09%	-171.29%	34.08%	-90.88%	21.99%	3.93%	18.60%	21.88%	19.20%
Return on Equity Simple (ROE_SIMPLE)	-26.55%	-11.19%	132.16%	34.17%	-206.43%	21.57%	4.27%	19.01%	21.83%	19.42%
Net Operating Profit after Tax (NOPAT)	883	375	-425	894	-2,869	1,606	88	1,426	1,546	1,332
NOPAT Margin	0.39%	0.18%	-0.23%	0.55%	-1.88%	1.10%	0.06%	1.10%	1.27%	1.30%
Net Nonoperating Expense Percent (NNEP)	13.59%	7.90%	42.29%	9.69%	17.35%	3.95%	-3.34%	3.94%	5.67%	11.75%
Cost of Revenue to Revenue	96.73%	96.65%	96.42%	95.83%	95.51%	95.30%	94.75%	94.97%	94.62%	94.43%
SG&A Expenses to Revenue	2.20%	2.34%	2.49%	2.79%	2.99%	3.08%	3.36%	2.90%	3.00%	3.16%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.72%	2.99%	3.91%	3.88%	7.17%	3.28%	5.16%	3.40%	3.36%	3.46%
Earnings before Interest and Taxes (EBIT)	1,252	747	-629	519	-4,097	2,045	103	2,125	2,454	2,168
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,962	1,439	63	1,302	-3,184	3,045	1,135	2,842	3,095	2,619
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	8.51	7.56	1.89	2.05	2.87	3.01	3.37
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	88.54
Price to Revenue (P/Rev)	0.11	0.12	0.08	0.09	0.09	0.08	0.09	0.15	0.16	0.21
Price to Earnings (P/E)	27.96	71.49	0.00	24.95	0.00	8.80	48.62	15.20	13.84	17.34
Dividend Yield	2.05%	2.15%	3.94%	3.71%	4.16%	4.75%	4.65%	2.92%	2.66%	2.22%
Earnings Yield	3.58%	1.40%	0.00%	4.01%	0.00%	11.37%	2.06%	6.58%	7.23%	5.77%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	5.00	3.03	1.48	1.54	2.22	2.34	3.04
Enterprise Value to Revenue (EV/Rev)	0.10	0.12	0.08	0.11	0.11	0.12	0.14	0.18	0.19	0.21
Enterprise Value to EBITDA (EV/EBITDA)	12.12	16.83	225.39	13.89	0.00	5.74	17.36	8.17	7.45	8.27
Enterprise Value to EBIT (EV/EBIT)	19.00	32.42	0.00	34.83	0.00	8.55	191.35	10.93	9.40	9.99
Enterprise Value to NOPAT (EV/NOPAT)	26.94	64.51	0.00	20.21	0.00	10.89	223.46	16.29	14.92	16.27
Enterprise Value to Operating Cash Flow (EV/OCF)	6.32	8.52	4.47	7.44	8.95	6.43	7.12	19.62	7.76	8.53
Enterprise Value to Free Cash Flow (EV/FCFF)	13.57	8.98	4.30	5.88	5.54	6.85	0.00	27.82	0.00	12.69
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.59	-1.59	-7.53	3.48	3.78	1.27	1.48	1.50	0.83	0.83
Long-Term Debt to Equity	-1.45	-1.32	-6.71	2.99	3.78	1.20	1.32	1.31	0.74	0.83
Financial Leverage	-0.07	-0.31	2.23	1.63	1.17	0.98	0.79	0.49	0.31	0.16
Leverage Ratio	-14.34	-23.81	81.19	23.76	10.06	6.52	6.15	5.44	4.96	4.44
Compound Leverage Factor	-13.76	-21.14	101.19	14.79	9.26	5.59	-13.62	4.93	4.60	4.03
Debt to Total Capital	270.85%	269.55%	115.32%	77.66%	79.08%	55.92%	59.75%	59.94%	45.30%	45.44%
Short-Term Debt to Total Capital	23.09%	45.41%	12.58%	10.85%	0.12%	3.15%	6.64%	7.65%	4.80%	0.00%
Long-Term Debt to Total Capital	247.77%	224.14%	102.73%	66.81%	78.97%	52.77%	53.12%	52.29%	40.50%	45.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.05%	0.06%	0.07%	0.04%	0.04%	0.01%	0.08%	0.80%	1.10%	0.00%
Common Equity to Total Capital	-170.90%	-169.61%	-15.38%	22.30%	20.88%	44.06%	40.17%	39.26%	53.60%	54.56%
Debt to EBITDA	2.60	3.27	84.37	4.79	-2.13	2.64	7.94	3.66	1.79	1.99
Net Debt to EBITDA	-0.02	0.43	9.49	2.17	-1.26	1.81	6.39	1.24	1.03	0.23
Long-Term Debt to EBITDA	2.37	2.72	75.16	4.12	-2.12	2.49	7.06	3.19	1.60	1.99
Debt to NOPAT	5.77	12.52	-12.51	6.97	-2.36	5.00	102.19	7.29	3.58	3.91
Net Debt to NOPAT	-0.05	1.66	-1.41	3.16	-1.40	3.42	82.20	2.47	2.06	0.45
Long-Term Debt to NOPAT	5.28	10.41	-11.14	6.00	-2.36	4.72	90.84	6.36	3.20	3.91
Altman Z-Score	5.39	5.07	4.32	4.04	3.74	4.16	3.87	4.16	4.57	4.61
Noncontrolling Interest Sharing Ratio	-0.03%	-0.11%	0.55%	0.17%	0.06%	0.11%	1.15%	2.00%	1.04%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.98	1.00	1.08	1.12	1.10	1.07	1.07	1.34	1.11	1.26
Quick Ratio	0.48	0.45	0.50	0.45	0.47	0.46	0.42	0.70	0.50	0.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,753	2,697	3,301	3,072	3,165	2,554	-2,228	835	-1,193	1,708
Operating Cash Flow to CapEx	753.91%	606.40%	891.85%	607.25%	525.47%	829.88%	720.83%	305.94%	638.92%	846.67%
Free Cash Flow to Firm to Interest Expense	34.37	32.11	21.03	15.84	12.46	8.69	-6.73	4.15	-6.70	8.50
Operating Cash Flow to Interest Expense	73.76	33.86	20.22	12.52	7.72	9.26	8.36	5.89	16.69	12.64
Operating Cash Flow Less CapEx to Interest Expense	63.98	28.27	17.96	10.46	6.25	8.14	7.20	3.97	14.08	11.14
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	5.13	4.70	4.11	3.81	3.74	3.60	3.42	3.50	3.78	3.65
Accounts Receivable Turnover	19.56	18.92	18.44	18.71	18.30	17.91	17.27	16.82	17.45	17.23
Inventory Turnover	14.12	12.48	11.57	11.20	11.23	11.04	10.98	11.26	11.60	11.08
Fixed Asset Turnover	90.91	85.02	76.82	68.75	64.77	60.10	62.67	70.74	73.62	69.16
Accounts Payable Turnover	7.11	6.94	6.88	6.91	6.81	6.73	6.90	7.01	7.26	7.30
Days Sales Outstanding (DSO)	18.66	19.29	19.79	19.51	19.94	20.38	21.14	21.70	20.91	21.19
Days Inventory Outstanding (DIO)	25.85	29.25	31.55	32.58	32.51	33.07	33.24	32.40	31.46	32.94
Days Payable Outstanding (DPO)	51.31	52.57	53.05	52.84	53.62	54.23	52.91	52.06	50.26	49.98
Cash Conversion Cycle (CCC)	-6.81	-4.02	-1.71	-0.75	-1.16	-0.79	1.47	2.04	2.11	4.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-3,300	-2,430	-108	3,618	5,796	11,830	12,778	10,462	9,871	7,132
Invested Capital Turnover	-79.17	-161.53	103.32	34.52	17.35	11.83	11.77	12.78	14.30	14.01
Increase / (Decrease) in Invested Capital	-870	-2,322	-3,726	-2,178	-6,034	-948	2,316	591	2,739	-376
Enterprise Value (EV)	23,784	24,217	14,199	18,078	17,538	17,490	19,709	23,226	23,062	21,667
Market Capitalization	23,824	23,591	13,598	15,246	13,531	11,988	12,447	19,572	19,745	21,072
Book Value per Share	($13.19)	($11.62)	($2.60)	$6.17	$6.13	$21.23	$19.50	$21.55	$20.12	$18.91
Tangible Book Value per Share	($39.67)	($35.52)	($30.61)	($28.62)	($32.49)	($18.39)	($19.86)	($7.59)	($8.81)	$0.72
Total Capital	1,880	1,744	4,609	8,030	8,567	14,361	15,084	17,341	12,227	11,467
Total Debt	5,092	4,701	5,315	6,236	6,775	8,031	9,013	10,395	5,539	5,211
Total Long-Term Debt	4,658	3,909	4,735	5,365	6,765	7,579	8,012	9,068	4,952	5,211
Net Debt	-41	625	598	2,829	4,004	5,500	7,250	3,516	3,183	595
Capital Expenditures (CapEx)	499	469	356	400	373	328	384	387	465	300
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5,455	-3,287	-1,752	888	-436	-441	898	1,572	486	-107
Debt-free Net Working Capital (DFNWC)	-322	789	2,965	4,295	2,335	2,090	2,661	8,451	2,842	4,509
Net Working Capital (NWC)	-756	-3.00	2,385	3,424	2,325	1,638	1,660	7,124	2,255	4,509
Net Nonoperating Expense (NNE)	30	44	512	282	824	241	-171	132	115	117
Net Nonoperating Obligations (NNO)	-88	527	598	1,824	4,004	5,500	6,707	3,516	3,183	876
Total Depreciation and Amortization (D&A)	710	692	692	783	913	1,000	1,032	717	641	451
Debt-free, Cash-free Net Working Capital to Revenue	-2.40%	-1.60%	-0.97%	0.55%	-0.29%	-0.30%	0.66%	1.21%	0.40%	-0.10%
Debt-free Net Working Capital to Revenue	-0.14%	0.38%	1.64%	2.64%	1.53%	1.44%	1.95%	6.50%	2.34%	4.40%
Net Working Capital to Revenue	-0.33%	0.00%	1.32%	2.11%	1.52%	1.13%	1.21%	5.48%	1.86%	4.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.48	$1.00	($3.35)	$2.09	($12.61)	$4.55	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	245M	261M	279M	292M	293M	300M	0.00	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$3.45	$1.00	($3.35)	$2.08	($12.61)	$4.53	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	247M	262M	279M	294M	293M	301M	0.00	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	243.85M	250.68M	272.51M	290.44M	292.44M	298.13M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	1,513	1,252	1,154	1,256	1,240	1,351	1,315	1,508	1,532	1,350
Normalized NOPAT Margin	0.67%	0.61%	0.64%	0.77%	0.81%	0.93%	0.96%	1.16%	1.26%	1.32%
Pre Tax Income Margin	0.53%	0.32%	-0.43%	0.20%	-2.47%	1.20%	-0.17%	1.48%	1.87%	1.92%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	24.55	8.89	-4.01	2.68	-16.13	6.96	0.31	10.57	13.79	10.79
NOPAT to Interest Expense	17.31	4.47	-2.71	4.61	-11.29	5.46	0.27	7.09	8.69	6.62
EBIT Less CapEx to Interest Expense	14.76	3.31	-6.27	0.61	-17.60	5.84	-0.85	8.65	11.17	9.29
NOPAT Less CapEx to Interest Expense	7.53	-1.11	-4.97	2.55	-12.76	4.35	-0.89	5.17	6.07	5.13
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	58.50%	159.52%	-59.66%	93.63%	-15.41%	42.27%	224.32%	44.59%	35.78%	37.86%
Augmented Payout Ratio	146.42%	763.75%	-166.38%	126.31%	-24.88%	86.23%	436.68%	90.96%	81.27%	123.13%

This table displays calculated financial ratios and metrics derived from Cardinal Health's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.02%	-3.79%	-4.34%	11.77%	8.76%	11.61%	10.17%	13.50%	12.60%	13.23%	12.82%
EBITDA Growth	72.94%	6.96%	443.17%	76.22%	-26.24%	1,089.66%	-54.58%	95.24%	822.22%	107.50%	-47.87%
EBIT Growth	99.73%	6.02%	1,836.36%	157.89%	-34.62%	559.82%	-124.44%	1,481.82%	672.00%	88.05%	-67.78%
NOPAT Growth	97.27%	18.37%	2,054.52%	7,142.65%	-23.60%	536.92%	-116.20%	-80.98%	637.35%	87.47%	-54.81%
Net Income Growth	93.89%	8.67%	3,890.91%	7,700.00%	-25.36%	383.85%	-109.91%	-97.73%	124.96%	-365.31%	-59.19%
EPS Growth	0.00%	0.00%	3,500.00%	0.00%	0.00%	0.00%	-112.50%	0.00%	0.00%	0.00%	-57.45%
Operating Cash Flow Growth	10,903.70%	-133.93%	-411.93%	140.67%	-103.60%	97.49%	2,195.65%	-71.66%	424.82%	-50.04%	103.56%
Free Cash Flow Firm Growth	-5,504.99%	-220.55%	-145.56%	-52.22%	-101.30%	-22.92%	-44.22%	-37.88%	215.30%	387.19%	315.70%
Invested Capital Growth	311.60%	124.80%	61.52%	-35.80%	22.80%	-450.83%	-53,220.00%	-2,150.00%	-157.51%	-117.34%	-100.11%
Revenue Q/Q Growth	-0.70%	5.71%	-12.45%	8.74%	-4.41%	5.11%	2.30%	5.81%	-1.91%	3.76%	5.39%
EBITDA Q/Q Growth	28.18%	-2.25%	30.62%	4.90%	-18.13%	396.40%	-57.62%	-56.09%	1,187.93%	-81.05%	82.14%
EBIT Q/Q Growth	35.35%	-4.71%	46.17%	4.81%	-24.90%	1,660.61%	-121.71%	-73.43%	610.71%	-182.96%	1,327.27%
NOPAT Q/Q Growth	29.44%	-1.60%	81.60%	-13.51%	-19.95%	1,724.80%	-772.92%	-99.09%	538.01%	-160.26%	689.97%
Net Income Q/Q Growth	26.68%	-3.84%	78.21%	-9.65%	-26.84%	3,454.55%	-466.67%	-99.14%	366.92%	-217.12%	-15.91%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	829.25%	75.71%	-179.30%	4,338.78%	-104.12%	123.30%	-38.82%	-36.59%	127.97%	2,495.65%	-99.24%
Free Cash Flow Firm Q/Q Growth	19.69%	-209.53%	-208.20%	2,040.70%	-101.86%	16.99%	13.47%	-47.17%	9.92%	-15.34%	26.36%
Invested Capital Q/Q Growth	191.88%	180.41%	68.91%	-189.98%	65.80%	-24.79%	-9.71%	-64.86%	-144.04%	-11,980.00%	95.37%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	3.87%	3.51%	3.64%	3.10%	3.55%	3.23%	3.19%	3.39%	3.54%	3.23%	3.25%
EBITDA Margin	1.72%	1.34%	1.44%	0.97%	1.00%	1.20%	0.25%	0.61%	1.48%	0.11%	0.62%
Operating Margin	1.33%	0.99%	1.09%	0.68%	0.67%	0.88%	-0.06%	0.30%	1.13%	-0.23%	0.28%
EBIT Margin	1.35%	0.99%	1.10%	0.66%	0.68%	0.90%	-0.06%	0.28%	1.13%	-0.22%	0.27%
Profit (Net Income) Margin	0.93%	0.73%	0.80%	0.39%	0.47%	0.64%	-0.02%	0.01%	0.69%	-0.25%	0.22%
Tax Burden Percent	76.39%	78.47%	77.08%	59.09%	75.95%	72.07%	25.00%	2.05%	63.79%	94.89%	100.91%
Interest Burden Percent	89.99%	93.59%	94.42%	101.02%	91.18%	99.42%	133.33%	96.05%	95.10%	122.32%	81.48%
Effective Tax Rate	23.61%	21.53%	22.92%	40.91%	24.05%	27.93%	0.00%	97.95%	36.21%	0.00%	-0.91%
Return on Invested Capital (ROIC)	355.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	263.62%	-21.69%	22.74%
ROIC Less NNEP Spread (ROIC-NNEP)	354.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	262.73%	-23.97%	21.65%
Return on Net Nonoperating Assets (RNNOA)	-441.34%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-361.01%	81.03%	-279.94%
Return on Equity (ROE)	-85.63%	-41.24%	-37.87%	-27.65%	-22.70%	-25.02%	-7.93%	-18.07%	-97.39%	59.34%	-257.20%
Cash Return on Invested Capital (CROIC)	-78.22%	-335.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	6.25%	4.69%	5.67%	3.37%	3.37%	4.25%	-0.29%	1.34%	5.26%	-0.95%	1.18%
Return on Assets (ROA)	4.30%	3.45%	4.13%	2.01%	2.33%	3.05%	-0.10%	0.03%	3.19%	-1.11%	0.97%
Return on Common Equity (ROCE)	-103.10%	-41.70%	-37.88%	-27.66%	-22.72%	-25.04%	-7.93%	-18.09%	-97.59%	59.59%	-259.88%
Return on Equity Simple (ROE_SIMPLE)	-52.88%	-43.90%	-39.09%	0.00%	-19.05%	-20.53%	-5.99%	0.00%	-20.72%	57.70%	61.65%
Net Operating Profit after Tax (NOPAT)	558	431	438	241	279	364	-22	3.33	365	-83	138
NOPAT Margin	1.02%	0.78%	0.84%	0.40%	0.51%	0.63%	-0.04%	0.01%	0.72%	-0.16%	0.28%
Net Nonoperating Expense Percent (NNEP)	1.54%	1.54%	1.35%	3.23%	1.38%	-0.58%	-0.88%	0.06%	0.89%	2.28%	1.10%
Return On Investment Capital (ROIC_SIMPLE)	9.65%	9.20%	-	-	-	28.52%	-	-	-	-	-
Cost of Revenue to Revenue	96.13%	96.49%	96.36%	96.90%	96.45%	96.77%	96.81%	96.61%	96.46%	96.77%	96.75%
SG&A Expenses to Revenue	2.40%	2.36%	2.44%	2.07%	2.33%	2.21%	2.17%	2.31%	2.34%	2.31%	2.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.54%	2.52%	2.55%	2.42%	2.88%	2.35%	3.25%	3.09%	2.40%	3.46%	2.98%
Earnings before Interest and Taxes (EBIT)	739	546	573	392	374	515	-33	152	572	-112	135
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	946	738	755	578	551	690	139	328	747	58	306
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.15	0.13	0.12	0.11	0.12	0.11	0.10	0.12	0.10	0.10	0.09
Price to Earnings (P/E)	21.30	21.72	20.96	27.96	43.60	34.55	102.05	71.49	41.39	0.00	0.00
Dividend Yield	1.47%	1.71%	1.82%	2.05%	1.80%	2.02%	2.35%	2.15%	2.69%	2.66%	3.08%
Earnings Yield	4.70%	4.60%	4.77%	3.58%	2.29%	2.89%	0.98%	1.40%	2.42%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	16.01	39.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.17	0.15	0.13	0.10	0.13	0.11	0.11	0.12	0.10	0.11	0.10
Enterprise Value to EBITDA (EV/EBITDA)	12.75	12.33	11.30	12.12	17.07	12.88	17.34	16.83	15.38	34.45	0.00
Enterprise Value to EBIT (EV/EBIT)	17.08	17.13	15.68	19.00	28.87	20.33	38.09	32.42	33.69	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	23.19	23.32	22.03	26.94	44.81	33.23	92.12	64.51	32.97	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.06	4,045.78	18.35	6.32	11.47	6.24	6.58	8.52	3.92	6.51	5.01
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	13.57	92.43	7.09	7.60	8.98	4.25	5.21	4.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-4.05	-2.60	-1.58	-1.59	-1.79	-1.37	-1.34	-1.59	-2.12	-2.38	-2.96
Long-Term Debt to Equity	-3.76	-2.42	-1.29	-1.45	-1.43	-1.03	-1.11	-1.32	-2.12	-2.12	-2.63
Financial Leverage	-1.25	-0.61	-0.45	-0.07	-0.52	-0.31	-0.49	-0.31	-1.37	-3.38	-12.93
Leverage Ratio	-18.56	-14.69	-12.82	-14.34	-16.29	-16.09	-16.53	-23.81	-29.37	-72.86	-224.95
Compound Leverage Factor	-16.70	-13.75	-12.11	-14.49	-14.85	-16.00	-22.04	-22.87	-27.93	-89.12	-183.29
Debt to Total Capital	132.83%	162.35%	273.52%	270.85%	225.85%	370.14%	393.77%	269.55%	189.08%	172.52%	151.05%
Short-Term Debt to Total Capital	9.39%	11.61%	49.79%	23.09%	45.79%	93.10%	66.33%	45.41%	0.00%	18.92%	16.58%
Long-Term Debt to Total Capital	123.44%	150.74%	223.73%	247.77%	180.05%	277.04%	327.44%	224.14%	189.08%	153.61%	134.47%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	18.16%	1.49%	0.05%	0.05%	0.12%	0.16%	0.08%	0.06%	0.08%	0.03%	0.03%
Common Equity to Total Capital	-50.99%	-63.84%	-173.57%	-170.90%	-125.96%	-270.30%	-293.86%	-169.61%	-89.16%	-72.56%	-51.08%
Debt to EBITDA	2.54	2.90	2.00	2.60	3.42	2.48	3.68	3.27	3.68	8.58	-24.16
Net Debt to EBITDA	1.44	1.45	0.89	-0.02	1.25	0.07	0.65	0.43	0.56	2.62	-8.14
Long-Term Debt to EBITDA	2.36	2.69	1.64	2.37	2.73	1.86	3.06	2.72	3.68	7.64	-21.51
Debt to NOPAT	4.62	5.48	3.91	5.77	8.98	6.40	19.54	12.52	7.89	-139.21	-8.50
Net Debt to NOPAT	2.62	2.73	1.74	-0.05	3.28	0.18	3.44	1.66	1.20	-42.54	-2.87
Long-Term Debt to NOPAT	4.29	5.09	3.20	5.28	7.16	4.79	16.25	10.41	7.89	-123.94	-7.57
Altman Z-Score	4.86	5.13	5.56	5.32	5.14	4.94	5.04	5.03	4.89	4.60	4.57
Noncontrolling Interest Sharing Ratio	-20.41%	-1.13%	-0.03%	-0.03%	-0.09%	-0.05%	-0.04%	-0.11%	-0.21%	-0.41%	-1.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.94	1.02	0.95	0.98	0.98	0.98	0.99	1.00	1.03	1.04	1.04
Quick Ratio	0.44	0.46	0.42	0.48	0.42	0.43	0.43	0.45	0.46	0.45	0.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2,988	-3,721	-1,202	1,111	-57	3,087	2,639	2,325	4,402	4,005	4,730
Operating Cash Flow to CapEx	2,371.54%	-404.04%	-1,830.00%	1,087.43%	-47.12%	1,043.36%	580.22%	416.91%	1,248.62%	702.35%	33.82%
Free Cash Flow to Firm to Interest Expense	-40.38	-106.32	-37.57	0.00	-1.73	1,028.99	239.87	387.55	157.21	160.19	189.21
Operating Cash Flow to Interest Expense	39.42	-11.43	-51.47	0.00	-1.48	393.00	48.00	143.83	48.61	23.88	0.92
Operating Cash Flow Less CapEx to Interest Expense	37.76	-14.26	-54.28	0.00	-4.64	355.33	39.73	109.33	44.71	20.48	-1.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	4.64	4.75	5.17	5.13	4.94	4.74	4.82	4.70	4.65	4.38	4.33
Accounts Receivable Turnover	18.35	18.40	19.48	19.56	19.55	18.61	18.83	18.92	18.70	18.53	18.38
Inventory Turnover	12.83	12.14	13.30	14.12	12.58	11.69	12.35	12.48	11.96	11.58	11.79
Fixed Asset Turnover	86.59	88.84	90.21	90.91	91.28	90.24	87.88	85.02	85.25	82.79	79.98
Accounts Payable Turnover	6.61	6.55	7.01	7.11	6.91	6.49	6.78	6.94	7.06	6.80	6.97
Days Sales Outstanding (DSO)	19.89	19.83	18.74	18.66	18.67	19.61	19.38	19.29	19.52	19.70	19.86
Days Inventory Outstanding (DIO)	28.46	30.06	27.44	25.85	29.02	31.21	29.55	29.25	30.52	31.52	30.95
Days Payable Outstanding (DPO)	55.23	55.75	52.09	51.31	52.82	56.24	53.85	52.57	51.72	53.67	52.34
Cash Conversion Cycle (CCC)	-6.88	-5.85	-5.92	-6.81	-5.13	-5.41	-4.91	-4.02	-1.69	-2.46	-1.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,408	825	-1,026	-3,300	-1,138	-3,327	-2,666	-2,430	-1,474	-604	-5.00
Invested Capital Turnover	350.06	-177.68	-121.59	-79.17	-168.87	-109.90	-157.26	-161.53	364.78	134.01	81.61
Increase / (Decrease) in Invested Capital	3,546	4,152	1,640	-870	336	-2,723	-2,661	-2,322	-4,037	-4,088	-4,592
Enterprise Value (EV)	38,562	32,366	29,124	23,784	29,217	24,523	22,052	24,217	19,677	21,118	19,257
Market Capitalization	33,159	28,500	26,826	23,824	27,078	24,389	21,227	23,591	18,957	19,509	17,481
Book Value per Share	($12.20)	($12.36)	($13.44)	($13.19)	($13.42)	($13.99)	($13.93)	($11.62)	($8.62)	($8.44)	($6.54)
Tangible Book Value per Share	($57.80)	($43.08)	($39.64)	($39.67)	($40.18)	($35.79)	($35.60)	($35.52)	($34.11)	($33.69)	($33.57)
Total Capital	5,781	4,685	1,888	1,880	2,592	1,276	1,188	1,744	2,490	3,050	3,487
Total Debt	7,679	7,606	5,164	5,092	5,854	4,723	4,678	4,701	4,708	5,262	5,267
Total Long-Term Debt	7,136	7,062	4,224	4,658	4,667	3,535	3,890	3,909	4,708	4,685	4,689
Net Debt	4,353	3,796	2,297	-41	2,136	132	824	625	718	1,608	1,775
Capital Expenditures (CapEx)	123	99	90	191	104	113	91	207	109	85	68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4,850	-2,733	-3,700	-5,455	-3,103	-4,031	-3,443	-3,287	-2,996	-1,693	-1,777
Debt-free Net Working Capital (DFNWC)	-1,524	1,077	-833	-322	615	560	411	789	994	1,961	1,715
Net Working Capital (NWC)	-2,067	533	-1,773	-756	-572	-628	-377	-3.00	994	1,384	1,137
Net Nonoperating Expense (NNE)	50	30	21	7.09	20	-5.04	-11	0.33	18	47	27
Net Nonoperating Obligations (NNO)	4,306	3,746	2,250	-88	2,124	120	824	527	744	1,608	1,775
Total Depreciation and Amortization (D&A)	207	192	182	186	177	175	172	176	175	170	171
Debt-free, Cash-free Net Working Capital to Revenue	-2.18%	-1.23%	-1.65%	-2.40%	-1.41%	-1.87%	-1.64%	-1.60%	-1.51%	-0.88%	-0.95%
Debt-free Net Working Capital to Revenue	-0.69%	0.48%	-0.37%	-0.14%	0.28%	0.26%	0.20%	0.38%	0.50%	1.02%	0.92%
Net Working Capital to Revenue	-0.93%	0.24%	-0.79%	-0.33%	-0.26%	-0.29%	-0.18%	0.00%	0.50%	0.72%	0.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$1.71	$0.00	$0.00	$0.00	$0.02	$0.00	$0.00	$0.00	$0.41
Adjusted Weighted Average Basic Shares Outstanding	240M	242M	243M	245M	243M	245M	249M	261M	256M	261M	271M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$1.70	$0.00	$0.00	$0.00	$0.02	$0.00	$0.00	$0.00	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	241M	243M	245M	247M	245M	246M	250M	262M	258M	261M	273M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	238.68M	241.57M	242.01M	243.85M	243.57M	243.23M	246.47M	250.68M	254.60M	257.64M	262.13M
Normalized Net Operating Profit after Tax (NOPAT)	486	416	425	318	444	377	345	357	339	281	242
Normalized NOPAT Margin	0.89%	0.75%	0.81%	0.53%	0.81%	0.66%	0.63%	0.67%	0.67%	0.55%	0.49%
Pre Tax Income Margin	1.21%	0.92%	1.03%	0.66%	0.62%	0.89%	-0.08%	0.27%	1.08%	-0.27%	0.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.99	15.60	17.91	0.00	11.33	171.67	-3.00	25.33	20.43	-4.48	5.40
NOPAT to Interest Expense	7.54	12.31	13.68	0.00	8.45	121.32	-2.04	0.55	13.03	-3.33	5.53
EBIT Less CapEx to Interest Expense	8.32	12.77	15.09	0.00	8.18	134.00	-11.27	-9.17	16.54	-7.88	2.68
NOPAT Less CapEx to Interest Expense	5.87	9.48	10.87	0.00	5.30	83.65	-10.31	-33.95	9.14	-6.73	2.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	31.82%	37.62%	38.72%	58.50%	81.35%	72.32%	247.37%	159.52%	115.87%	-42.36%	-50.27%
Augmented Payout Ratio	80.89%	67.33%	87.51%	146.42%	282.32%	284.18%	965.07%	763.75%	441.96%	-155.91%	-186.89%

Frequently Asked Questions About Cardinal Health's Financials

When does Cardinal Health's fiscal year end?

According to the most recent income statement we have on file, Cardinal Health's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has Cardinal Health's net income changed over the last 9 years?

Cardinal Health's net income appears to be on a downward trend, with a most recent value of $853 million in 2024, falling from $1.22 billion in 2015. The previous period was $331 million in 2023. Check out Cardinal Health's forecast to explore projected trends and price targets.

What is Cardinal Health's operating income?

Cardinal Health's total operating income in 2024 was $1.24 billion, based on the following breakdown:

Total Gross Profit: $7.41 billion
Total Operating Expenses: $6.17 billion

How has Cardinal Health revenue changed over the last 9 years?

Over the last 9 years, Cardinal Health's total revenue changed from $102.53 billion in 2015 to $226.83 billion in 2024, a change of 121.2%.

How much debt does Cardinal Health have?

Cardinal Health's total liabilities were at $48.33 billion at the end of 2024, a 4.4% increase from 2023, and a 104.8% increase since 2015.

How much cash does Cardinal Health have?

In the past 9 years, Cardinal Health's cash and equivalents has ranged from $1.76 billion in 2018 to $6.88 billion in 2017, and is currently $5.13 billion as of their latest financial filing in 2024.

How has Cardinal Health's book value per share changed over the last 9 years?

Over the last 9 years, Cardinal Health's book value per share changed from 18.91 in 2015 to -13.19 in 2024, a change of -169.8%.

Related Companies

This page (NYSE:CAH) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Financials

Frequently Asked Questions About Cardinal Health's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cardinal Health (CAH) Financials

Annual Income Statements for Cardinal Health

Quarterly Income Statements for Cardinal Health

Annual Cash Flow Statements for Cardinal Health

Quarterly Cash Flow Statements for Cardinal Health

Annual Balance Sheets for Cardinal Health

Quarterly Balance Sheets for Cardinal Health

Annual Metrics And Ratios for Cardinal Health

Quarterly Metrics And Ratios for Cardinal Health

Frequently Asked Questions About Cardinal Health's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools